Preliminary 6-month results from the first-in-human trial of deep brain stimulation (DBS) of the subgenual singulate cortex (SCC) for chronic low back pain, suggested that the procedure reduces pain, ...

Catheter-based polarization-sensitive optical coherence tomography (PS-OCT) enables high-resolution intraoperative visualization of deep brain structures, offering a powerful complement to MRI for ...

A groundbreaking international clinical trial has been testing an implanted adaptive deep brain stimulation (aDBS) device as a treatment therapy for Parkinson’s.

Deep brain stimulation can significantly reduce depressive symptoms in some individuals. Knowing what to expect before and after the procedure may help you determine if it’s right for you. Deep brain ...

Subthalamic nucleus deep brain stimulation (STN-DBS) provides lasting benefits for patients with moderate-to-advanced Parkinson’s disease (PD), with sustained improvements in movement and quality of ...

Shortly after obtaining a greenlight in Europe and after more than 10 years in development, Medtronic has now received the FDA’s approval for its adaptive, closed-loop neurostimulation approach to ...

Add Yahoo as a preferred source to see more of our stories on Google. New ultrasound helmet precisely targets deep brain regions without surgery, opening doors for research and treatment of brain ...

Deep brain stimulation (DBS) involves stimulating certain parts of your brain with implanted electrodes. It’s a promising treatment for treatment-resistant OCD. The main treatments for OCD are talk ...

Deep brain stimulation is a surgical brain therapy used to treat symptoms of movement disorders such as dystonia, Parkinson’s disease and epilepsy. Performing over 100 DBS procedures annually, the ...

There is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain stimulator that could benefit patients with the motor condition. On Feb 24, ...

Abbott Laboratories is launching a clinical trial applying its deep brain stimulation system to a tough-to-treat form of depression. The company called its "Transcend" study a pivotal trial for ...